Search Results - "Polus, Marc"

FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer by Lovinfosse, Pierre, Polus, Marc, Van Daele, Daniel, Martinive, Philippe, Daenen, Frédéric, Hatt, Mathieu, Visvikis, Dimitris, Koopmansch, Benjamin, Lambert, Frédéric, Coimbra, Carla, Seidel, Laurence, Albert, Adelin, Delvenne, Philippe, Hustinx, Roland

“…Purpose The aim of this study was to investigate the prognostic value of baseline 18 F-FDG PET/CT textural analysis in locally-advanced rectal cancer (LARC)…”
Get full text

Adjuvant Gemcitabine Alone Versus Gemcitabine-Based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: A Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study by VAN LAETHEM, Jean-Luc, HAMMEL, Pascal, COLLETTE, Laurence, BUDACH, Volker, LUTZ, Manfred, VAN CUTSEM, Eric, HAUSTERMANS, Karin, MORNEX, Françoise, AZRIA, David, VAN TIENHOVEN, Geertjan, VERGAUWE, Philippe, PEETERS, Marc, POLUS, Marc, PRAET, Michel, MAUER, Murielle

“…The role of adjuvant chemoradiotherapy (CRT) in resectable pancreatic cancer is still debated. This randomized phase II intergroup study explores the…”
Get full text

Human Equilibrative Nucleoside Transporter 1 and Human Concentrative Nucleoside Transporter 3 Predict Survival after Adjuvant Gemcitabine Therapy in Resected Pancreatic Adenocarcinoma by Maréchal, Raphaël, Mackey, John R, Lai, Raymond, Demetter, Pieter, Peeters, Marc, Polus, Marc, Cass, Carol E, Young, James, Salmon, Isabelle, Devière, Jacques, Van Laethem, Jean-Luc

“…Purpose: Gemcitabine is a promising adjuvant treatment for patients with resected pancreatic adenocarcinoma and its use in combination with radiotherapy is…”
Get full text

OLFM4, KNG1 and Sec24C identified by proteomics and immunohistochemistry as potential markers of early colorectal cancer stages by Quesada-Calvo, Florence, Massot, Charlotte, Bertrand, Virginie, Longuespée, Rémi, Blétard, Noëlla, Somja, Joan, Mazzucchelli, Gabriel, Smargiasso, Nicolas, Baiwir, Dominique, De Pauw-Gillet, Marie-Claire, Delvenne, Philippe, Malaise, Michel, Coimbra Marques, Carla, Polus, Marc, De Pauw, Edwin, Meuwis, Marie-Alice, Louis, Edouard

“…Despite recent advances in colorectal cancer (CRC) diagnosis and population screening programs, the identification of patients with preneoplastic lesions or…”
Get full text

Carcinoid tumor of the appendix： A consecutive series from 1237 appendectomies by Tchana-Sato, Vincent, Detry, Olivier, Polus, Marc, Thiry, Albert, Detroz, Bernard, Maweja, Sylvie, Hamoir, Etienne, Defechereux, Thierry, Coimbra, Carla, De Roover, Arnaud, Meurisse, Michel, Honoré, Pierre

“…AIM： To report the experience of the CHU Sart Tilman, University of Liege, Belgium, in the management of appendiceal carinoid tumor. METHODS： A retrospective…”
Get full text

Oncological patients' reactions to COVID‐19 pandemic: A single institution prospective study by Onesti, Concetta Elisa, Schroeder, Hélène, Rorive, Andrée, Sautois, Brieuc, Lecocq, Marie, Goffin, Marie, Gonne, Elodie, Collinge, Astrid, Nicolaers, Laurence, Wéra, Odile, Catot, Amandine, Loly, Catherine, Paulus, Astrid, Sibille, Anne, Lousberg, Laurence, Troisfontaine, Florence, Collignon, Joëlle, Gennigens, Christine, Frères, Pierre, Polus, Marc, Duysinx, Bernard, Vaillant, Frédérique, Marchal, Nathalie, Poncin, Aurélie, Jerusalem, Guy

“…Background The spread of the COVID‐19 pandemic has led to a rapid reorganization in all human and hospital activities, with impact on cancer patients. Aim An…”
Get full text

Use of cinacalcet and sunitinib to treat hypercalcaemia due to a pancreatic neuroendocrine tumor by Valdes-Socin, Hernan, Almanza, Matilde Rubio, Fernández-Ladreda, Mariana Tomé, Daele, Daniel Van, Polus, Marc, Chavez, Marcela, Beckers, Albert

“…Neuroendocrine tumors (NETs) can secrete hormones, including ectopic secretions, but they have been rarely associated with malignant hypercalcemia. A…”
Get full text

Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: a phase II study by Van Laethem, Jean-Luc, Demols, Anne, Gay, France, Closon, Marie-Thérèse, Collette, Maryvone, Polus, Marc, Houbiers, Ghislain, Gastelblum, Pauline, Gelin, Michel, Houtte, Paul Van, Closset, Jean

“…The addition of radiation to adjuvant 5-fluorouracil for the treatment of pancreatic cancer has not yet shown any definite benefit. Gemcitabine (GEM) has…”
Get more information

Benefits of switching from guaiac-based faecal occult blood to faecal immunochemical testing: experience from the Wallonia–Brussels colorectal cancer screening programme by Guo, Feng, De Brabander, Isabel, Francart, Julie, Candeur, Michel, Polus, Marc, Van Eycken, Liesbet, Brenner, Hermann

“…Background Faecal immunochemical tests (FITs) have replaced guaiac-based faecal occult blood test (gFOBTs) in several colorectal cancer (CRC) screening…”
Get full text

(18)F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status by Lovinfosse, Pierre, Koopmansch, Benjamin, Lambert, Frederic, Jodogne, Sébastien, Kustermans, Gaelle, Hatt, Mathieu, Visvikis, Dimitris, Seidel, Laurence, Polus, Marc, Albert, Adelin, Delvenne, Philippe, Hustinx, Roland

“…Treating metastatic colorectal cancer with anti-EGFR monoclonal antibodies is recommended only for patients whose tumour does not harbour mutations of KRAS or…”
Get full text

Correction: Benefits of switching from guaiac-based faecal occult blood to faecal immunochemical testing: experience from the Wallonia–Brussels colorectal cancer screening programme by Guo, Feng, De Brabander, Isabel, Francart, Julie, Candeur, Michel, Polus, Marc, Van Eycken, Liesbet, Brenner, Hermann

Get full text

Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study by Maréchal, R., Vos, B., Polus, M., Delaunoit, T., Peeters, M., Demetter, P., Hendlisz, A., Demols, A., Franchimont, D., Verset, G., Van Houtte, P., Van de Stadt, J., Van Laethem, J.L.

“…Induction chemotherapy has been suggested to impact on preoperative chemoradiation efficacy in locally advanced rectal cancer (LARC). To evaluate in LARC…”
Get full text

Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies by Heinemann, Volker, Sharma, Navesh K., Taieb, Julien, Ricke, Jens, Peeters, Marc, Strickland, Andrew, Gebski, Val, Van Buskirk, Mark, Zhao, Huaqing, van Hazel, Guy, Brown, Michael, Cardaci, Giuseppe, Clarke, Stephen, Ferguson, Tom, Ganju, Vinod, van Hazel, Guy, Liauw, Winston, Marx, Gavin, Matos, Marco, Price, Timothy, Ransom, David, Segelov, Eva, Shannon, Jenny, Singhal, Nimit, Strickland, Andrew, Delaunoit, Thierry, Deleporte, Amélie, Ferrante, Michel, Hendrickx, Koen, De Man, Marc, Polus, Marc, Chevallier, Patrick, Louafi, Samy, Pracht, Marc, Taieb, Julien, Bruch, Harald-Robert, Gehbauer, Gerald, Ko, Yon-Dschun, Kröning, Hendrik, Lammert, Frank, Nusch, Arnd, Ridwelski, Karsten, Riera-Knorrenschild, Jorge, Riera, Jorge Ramon, Sauerbruch, Tilmann, Scheidhauer, Klemens, Vehling-Kaiser, Ursula, Tichler, Thomas, Angelelli, Bruna, Isaacs, Richard, O’Donnell, Anne, Robinson, Bridget A., Rodríguez, Javier, Vera-Garcia, Ruth, Amin, Pradip, Chuong, Michael, Coveler, Andrew, Facchini, Francis, Frenette, Gary, Frick, Jacob, George, Benjamin, Gordon, Michael, Hannigan, James, Holtzman, Matthew, Kaubisch, Andreas, Kaiser, Adeel, Kooy, Todd, Limentani, Steven, Shibata, Stephen, Smith, Randall, Wang, Eric, Burge, Mathew, Cooray, Prasad, Singh, Madhu, Underhill, Craig, Deleporte, Amelie, Durand, Aurelie, Faivre, Sandrine, Ferru, Aurelie, Hammel, Pascal, Bremer, Christoph, De Wit, Maike, Ayala, Hubert, Heching, Norman, Shani, Adi, Masi, Gianluca, Trogu, Antonio, Sae-Won, Han, O'Donnell, Anne, Fragoso, Maria, Casado, Ana Ruiz, Liang, Jin Tung, Ades, Steven, Auber, Miklos, Bowers, Charles, Crain, Martin, Dowling, Kyran, Iyer, Renuka, Ratner, Lynn, Sanchez, Federico

“…The primary tumor side is emerging as a prognostic factor for patients with liver metastatic colorectal cancer (mCRC). In a combined analysis of data from 2…”
Get full text

High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma by Maréchal, R, Demetter, P, Nagy, N, Berton, A, Decaestecker, C, Polus, M, Closset, J, Devière, J, Salmon, I, Van Laethem, J-L

“…Chemokines and their receptors are involved in tumourigenicity and clinicopathological significance of chemokines receptor expression in pancreatic…”
Get full text

Digenic Inheritance of Mutations in Homologous Recombination Genes in Cancer Patients by Freire, Maria Valeria, Martin, Marie, Segers, Karin, Sepulchre, Edith, Leroi, Natacha, Coupier, Jérôme, Kalantari, Hassan Rezaei, Wolter, Pascal, Collignon, Joëlle, Polus, Marc, Plomteux, Olivier, Josse, Claire, Bours, Vincent

“…, , , and are known cancer predisposition genes (CPGs), but tumor risk in patients with simultaneous pathogenic variants (PVs) in CPGs remains largely unknown…”
Get full text

Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study by Gibbs, Peter, Gebski, Val, Van Buskirk, Mark, Thurston, Kenneth, Cade, David N, Van Hazel, Guy A

“…In colorectal cancer (CRC), unresectable liver metastases are linked to poor prognosis. Systemic chemotherapy with regimens such as FOLFOX (combination of…”
Get full text

Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma by Maréchal, Raphaël, Mackey, John R., Lai, Raymond, Demetter, Pieter, Peeters, Marc, Polus, Marc, Cass, Carol E., Salmon, Isabelle, Devière, Jacques, Van Laethem, Jean‐Luc

“…BACKGROUND: Gemcitabine (2′,2′‐difluorodeoxycytidine) administration after resection of pancreatic cancer improves both disease‐free survival (DFS) and overall…”
Get full text

18 F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status by Lovinfosse, Pierre, Koopmansch, Benjamin, Lambert, Frederic, Jodogne, Sébastien, Kustermans, Gaelle, Hatt, Mathieu, Visvikis, Dimitris, Seidel, Laurence, Polus, Marc, Albert, Adelin, Delvenne, Philippe, Hustinx, Roland

Get full text

Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study by Demols, A, Peeters, M, Polus, M, Marechal, R, Gay, F, Monsaert, E, Hendlisz, A, Van Laethem, J L

“…Gemcitabine and oxaliplatin (GEMOX) are active as first-line therapy against advanced pancreatic cancer. This study aims to evaluate the activity and…”
Get full text

18F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status by LOVINFOSSE, Pierre, KOOPMANSCH, Benjamin, LAMBERT, Frédéric, JODOGNE, Sébastien, KUSTERMANS, Gaëlle, Hatt, Mathieu, Visvikis, Dimitris, SEIDEL, Laurence, POLUS, Marc, Albert, Adelin, DELVENNE, Philippe, HUSTINX, Roland

“…OBJECTIVE: Treating metastatic colorectal cancer with anti-EGFR monoclonal antibodies is recommended only for patients whose tumour does not harbour mutations…”
Get full text